Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-03

Clinical Trial Update: Catheter Ablation of Ventricular Arrhythmia Reduces Skin Sympathetic Activity

View source ↗

Summary

A terminated clinical trial update reports that catheter ablation for ventricular tachycardia reduces skin sympathetic activity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Ventricular Tachycardia | Status: TERMINATED